Background and Aims: Left atrial appendage closure (LAAC) has emerged as an alternative for stroke prevention in patients with Non-Valvular Atrial Fibrillation (NVAF) and contraindications to oral anticoagulation (OAC). Percutaneous LAAC with Watchman compared to warfarin in NVAF patients with increased stroke risk showed a significant reduction in hemorrhagic stroke and a similar